Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction
Stopped unable to get MHRA approval for formulation in present form
Conditions
- Irritable Bowel Syndrome
- Post Infective Bowel Dysfunction
Interventions
- DRUG: Saccharomyces Cerevisiae CNCM I-3856
- DRUG: placebo
Sponsor
University of Nottingham
Collaborators